Showing results (41-50 of 94) with videos related to
Sort By:
Pageof 10
Molecular Therapy Oncolytics|March 20, 2023
A novel chemical attack on Notch-mediated transcription by targeting the NACK ATPaseGiulia Diluvio, Tanya T Kelley, Mohini Lahiry, et al.Cancers|March 16, 2019
Novel Curcumin Inspired Bis-Chalcone Promotes Endoplasmic Reticulum Stress and Glioblastoma Neurosphere Cell DeathLorenzo Sansalone, Eduardo A Veliz, Nadia G Myrthil, et al.Journal of Medicinal Chemistry|October 7, 2008
Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitorsYangbo Feng, Yan Yin, Amiee Weiser, et al.Nature Chemical Biology|October 23, 2012
Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitorsLikun Wang, B Gayani K Perera, Sanjay B Hari, et al.Drug Discovery Today|June 19, 2017
From flamingo dance to (desirable) drug discovery: a nature-inspired approachAminael Sánchez-Rodríguez, Yunierkis Pérez-Castillo, Stephan C Schürer, et al.Bioinformatics (Oxford, England)|April 12, 2017
TIN-X: target importance and novelty explorerDaniel C Cannon, Jeremy J Yang, Stephen L Mathias, et al.Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Benzimidazole- and benzoxazole-based inhibitors of Rho kinaseE Hampton Sessions, Yan Yin, Thomas D Bannister, et al.Scientific Data|June 20, 2018
Sustainable data and metadata management at the BD2K-LINCS Data Coordination and Integration CenterVasileios Stathias, Amar Koleti, Dušica Vidović, et al.Cancer Research Communications|May 9, 2022
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling PathwaysMarco Magistri, Lanie E Happ, Jeremy Ramdial, et al.Cancer Research Communications|August 31, 2023
Correction: The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling PathwaysMarco Magistri, Lanie E Happ, Jeremy Ramdial, et al.Pageof 10